Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Everis Medical has acquired Hood Laboratories, a medical devices business in Otolaryngology/Head and Neck Surgery and airway management in Michigan, for $202M. Hood Laboratories manufactures ENT, airway, and thoracic devices and has been producing specialized medical technology since 1962, supporting clinicians in Pembroke, Massachusetts and beyond. Everis Medical acquisitions expand its OHNS portfolio and create a meaningful entry into airway management, strengthening end-to-end solutions from diagnosis through post-operative care. The healthcare M&A is an add on acquisition and part of Everis Medical acquisitions, marking its fifth strategic purchase since 2019, with Everis Medical backed by private equity acquisition strategy.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026